Literature DB >> 24272839

Inosine analogs as anti-leishmanial agents.

P Rainey1, P A Nolan, L B Townsend, R K Robins, J J Fox, J A Secrist Iii, D V Santi.   

Abstract

Several criteria were used to select a number of inosine analogs as potential growth inhibitors of the protozoan parasite Leishmania tropica. Of nine compounds tested, seven showed a high degree of selective toxicity towards L. tropica promastigotes as compared to mouse L1210 cells; these include analogs of formycin B, 7-substituted analogs of 7-deazainosine and analogs of inosine in which the sugar moiety has been modified to confer metabolic stability. The metabolism of 7-deazainosine in L. tropica promastigotes was shown to involve conversion to cytotoxic adenosine nucleotide analogs (tubercidin derivatives) that become incorporated into RNA. The results suggest several new classes of compounds which have potential as anti-leishmanial agents.

Entities:  

Year:  1985        PMID: 24272839     DOI: 10.1023/A:1016360710842

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  18 in total

1.  Assay of intracellular free and macromolecular-bound metabolites of 5-fluorodeoxyuridine and 5-fluorouracil.

Authors:  W L Washtien; D V Santi
Journal:  Cancer Res       Date:  1979-09       Impact factor: 12.701

2.  Studies on formycin and formycin B in cells of Ehrlich carcinoma and E. coli.

Authors:  H Umezawa; T Sawa; Y Fukagawa; I Homma; M Ishizuka
Journal:  J Antibiot (Tokyo)       Date:  1967-11       Impact factor: 2.649

3.  Biological action of inosine analogs in Leishmania and Trypanosoma spp.

Authors:  J J Marr; R L Berens; N K Cohn; D J Nelson; R S Klein
Journal:  Antimicrob Agents Chemother       Date:  1984-02       Impact factor: 5.191

4.  Phosphorylation and anti-leishmanial activity of formycin B.

Authors:  D A Carson; K P Chang
Journal:  Biochem Biophys Res Commun       Date:  1981-06-16       Impact factor: 3.575

5.  Pharmacological disposition and metabolic fate of 2'-fluoro-5-iodo-1-beta-D-arabinofuranosylcytosine in mice and rats.

Authors:  T C Chou; A Feinberg; A J Grant; P Vidal; U Reichman; K A Watanabe; J J Fox; F S Philips
Journal:  Cancer Res       Date:  1981-09       Impact factor: 12.701

6.  The metabolism of formycin B in Leishmania donovani.

Authors:  D J Nelson; S W Lafon; T E Jones; T Spector; R L Berens; J J Marr
Journal:  Biochem Biophys Res Commun       Date:  1982-09-16       Impact factor: 3.575

7.  Allopurinol ribonucleoside as an antileishmanial agent. Biological effects, metabolism, and enzymatic phosphorylation.

Authors:  D J Nelson; S W LaFon; J V Tuttle; W H Miller; R L Miller; T A Krenitsky; G B Elion; R L Berens; J J Marr
Journal:  J Biol Chem       Date:  1979-11-25       Impact factor: 5.157

8.  Metabolism and mechanism of action of formycin B in Leishmania.

Authors:  P Rainey; D V Santi
Journal:  Proc Natl Acad Sci U S A       Date:  1983-01       Impact factor: 11.205

9.  Activity of purine analogs against Leishmania tropica within human macrophages in vitro.

Authors:  J D Berman; L S Lee; R K Robins; G R Revankar
Journal:  Antimicrob Agents Chemother       Date:  1983-08       Impact factor: 5.191

10.  Synthesis and antiviral activity of certain carbamoylpyrrolopyrimidine and pyrazolopyrimidine nucleosides.

Authors:  R J Goebel; A D Adams; P A McKernan; B K Murray; R K Robins; G R Revankar; P G Canonico
Journal:  J Med Chem       Date:  1982-11       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.